Salarius Pharmaceuticals
SLRX
SLRX
25 hedge funds and large institutions have $1.45M invested in Salarius Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16K | |
| 2 | +$8K | |
| 3 | +$7K | |
| 4 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$5K |
Top Sellers
| 1 | -$671K | |
| 2 | -$46.4K | |
| 3 | -$45K | |
| 4 |
Two Sigma Advisers
New York
|
-$39.4K |
| 5 |
1WM
1900 Wealth Management
San Antonio,
Texas
|
-$20K |